Flagyl and Mycamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flagyl (metronidazole) and Mycamine (micafungin sodium). Common drug interactions include aspartate aminotransferase increased among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Flagyl and Mycamine. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Flagyl?

Flagyl has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 25,897 Flagyl users. Check the latest studies of Flagyl.

What is Mycamine?

Mycamine has active ingredients of micafungin sodium. eHealthMe is studying from 2,237 Mycamine users. Check the latest studies of Mycamine.



On Jul, 27, 2026

42 people who take Flagyl and Mycamine together, and have interactions are studied.

Flagyl and Mycamine drug interactions.

What are the common drug interactions of Flagyl and Mycamine, by gender? *:

female:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Anaemia (lack of blood)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
  6. Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
  7. Hepatic enzyme increased
  8. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  9. Iron deficiency
  10. Septic shock (shock due to blood infection)

male:

  1. Decreased appetite
  2. Fatigue (feeling of tiredness)
  3. Pulmonary haemorrhage (acute bleeding from the lung)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  6. Staphylococcal infection (an infection with staphylococcus bacteria)
  7. Death
  8. Multiple myeloma (cancer of the plasma cells)
  9. Nausea (feeling of having an urge to vomit)
  10. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

What are the common drug interactions of Flagyl and Mycamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
  2. Diarrhoea haemorrhagic (bloody diarrhoea)
  3. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Pleural effusion (water on the lungs)
  6. Pyrexia (fever)
  7. Septic shock (shock due to blood infection)
  8. Tooth abscess (pus formation in tooth)
  9. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  10. Alanine aminotransferase increased

10-19:

n/a

20-29:

n/a

30-39:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Anaemia (lack of blood)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
  6. Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
  7. Hepatic enzyme increased
  8. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  9. Iron deficiency
  10. Alanine aminotransferase increased

40-49:

  1. Acute respiratory failure
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Multiple myeloma (cancer of the plasma cells)
  4. Nausea (feeling of having an urge to vomit)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Pain
  7. Pulmonary haemorrhage (acute bleeding from the lung)
  8. Pyrexia (fever)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Bacterial sepsis

50-59:

  1. Decreased appetite
  2. Fatigue (feeling of tiredness)
  3. Muscular weakness (muscle weakness)
  4. Neuralgia (pain in one or more nerves)
  5. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
  6. Presyncope
  7. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Angioimmunoblastic t-cell lymphoma stage iv (mature t-cell cancer of the blood or lymph vessel-stage iv)
  10. Cardiac arrest

60+:

  1. Acute hepatic failure
  2. Acute respiratory failure
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Septic shock (shock due to blood infection)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Anaemia (lack of blood)
  9. Blood bilirubin increased
  10. Bone marrow failure

What are the existing conditions these people have? *

  1. Pain: 25 people, 59.52%
  2. Nausea (feeling of having an urge to vomit): 21 people, 50.00%
  3. Stress And Anxiety: 18 people, 42.86%
  4. Diarrhea: 17 people, 40.48%
  5. Hypokalemia (low potassium): 14 people, 33.33%
  6. Insomnia (sleeplessness): 14 people, 33.33%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 14 people, 33.33%
  8. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 13 people, 30.95%
  9. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 13 people, 30.95%
  10. Psychotic Disorder: 13 people, 30.95%

* Approximation only. Some reports may have incomplete information.

Do you take Flagyl and Mycamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flagyl and Mycamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flagyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mycamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flagyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metronidazole and micafungin sodium (the active ingredients of Flagyl and Mycamine, respectively), and Flagyl and Mycamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: